Moors & Cabot’s Oscar Health OSCR Stock Holding History

Moors & Cabot’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,000	Closed	-$193K	–	869
2023 Q2	$193K	Buy	+24,000	New	+$177K	0.01%	751

Other funds holding OSCR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moors & Cabot's OSCR Position: Q3 2023 in Review

Moors & Cabot sold out of Oscar Health (OSCR) in Q3 2023, closing a stake of 24,000 shares — an estimated $193K sold.

Moors & Cabot first reported a position in OSCR in Q2 2023 and held it in 1 quarter. The position peaked at $193K in Q2 2023. 177 funds tracked by Wall St. Rank hold OSCR as of Q3 2023.

Moors & Cabot reported no remaining Oscar Health position as of Q3 2023 after selling out during the quarter.
Moors & Cabot sold 24,000 Oscar Health shares in Q3 2023, an estimated $193K.
Moors & Cabot first reported a position in Oscar Health in Q2 2023 and held it in 1 quarter.
Moors & Cabot's Oscar Health position peaked at $193K in Q2 2023.
177 funds tracked by Wall St. Rank held Oscar Health as of Q3 2023.

Based on Moors & Cabot's 13F filing for Q3 2023, filed 8 Nov 2023.